Coloplast A/S (CLPBY)
6.45
-0.06
(-0.92%)
USD |
OTCM |
Sep 18, 16:00
Coloplast Price to Book Value : 7.110 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 7.110 |
| September 17, 2026 | 7.176 |
| September 16, 2026 | 7.110 |
| September 15, 2026 | 7.187 |
| September 14, 2026 | 7.220 |
| September 11, 2026 | 7.242 |
| September 10, 2026 | 7.441 |
| September 09, 2026 | 7.430 |
| September 08, 2026 | 7.683 |
| September 04, 2026 | 7.815 |
| September 03, 2026 | 8.025 |
| September 02, 2026 | 8.157 |
| September 01, 2026 | 8.036 |
| August 31, 2026 | 7.870 |
| August 28, 2026 | 7.904 |
| August 27, 2026 | 7.892 |
| August 26, 2026 | 7.870 |
| August 25, 2026 | 8.003 |
| August 24, 2026 | 7.981 |
| August 21, 2026 | 7.584 |
| August 20, 2026 | 7.496 |
| August 19, 2026 | 7.694 |
| August 18, 2026 | 7.485 |
| August 17, 2026 | 7.253 |
| August 14, 2026 | 7.363 |
| Date | Value |
|---|---|
| August 13, 2026 | 7.396 |
| August 12, 2026 | 7.363 |
| August 11, 2026 | 7.544 |
| August 10, 2026 | 7.330 |
| August 07, 2026 | 7.496 |
| August 06, 2026 | 7.286 |
| August 05, 2026 | 7.385 |
| August 04, 2026 | 7.408 |
| August 03, 2026 | 7.496 |
| July 31, 2026 | 7.385 |
| July 30, 2026 | 7.452 |
| July 29, 2026 | 7.363 |
| July 28, 2026 | 7.330 |
| July 27, 2026 | 7.132 |
| July 24, 2026 | 6.823 |
| July 23, 2026 | 6.658 |
| July 22, 2026 | 6.878 |
| July 21, 2026 | 6.978 |
| July 20, 2026 | 7.088 |
| July 17, 2026 | 7.110 |
| July 16, 2026 | 7.033 |
| July 15, 2026 | 6.922 |
| July 14, 2026 | 6.713 |
| July 13, 2026 | 6.834 |
| July 10, 2026 | 6.746 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ambu A/S | 2.825 |
| Abbott Laboratories | 3.474 |
| AngioDynamics, Inc. | 3.769 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.722 |
Price to Book Value Related Metrics
| PE Ratio | 33.80 |
| PS Ratio | 3.273 |
| Price to Free Cash Flow | 15.13 |
| Price | 6.45 |
| Earnings Yield | 2.96% |
| Market Cap | 13.38B |
| Operating PE Ratio | 12.47 |
| Normalized PE Ratio | 18.72 |